Report cover image

Global Flowable Hemostats Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 192 Pages
SKU # APRC20360423

Description

Summary

According to APO Research, the global Flowable Hemostats market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Flowable Hemostats is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Flowable Hemostats is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Flowable Hemostats market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Flowable Hemostats is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Flowable Hemostats market include Teleflex Incorporated, Baxter International and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flowable Hemostats, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Flowable Hemostats, also provides the sales of main regions and countries. Of the upcoming market potential for Flowable Hemostats, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flowable Hemostats sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Flowable Hemostats market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Flowable Hemostats sales, projected growth trends, production technology, application and end-user industry.

Flowable Hemostats Segment by Company

Teleflex Incorporated
Baxter International
Johnson & Johnson
Flowable Hemostats Segment by Type

Porcine Gelatin
Bovine Gelatin
Flowable Hemostats Segment by Application

Orthopedic Surgery
General Surgery
Neuro and Spine Surgery
Cardiac Surgery
Vascular Surgery
Others
Flowable Hemostats Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Flowable Hemostats status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Flowable Hemostats market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Flowable Hemostats significant trends, drivers, influence factors in global and regions.
6. To analyze Flowable Hemostats competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flowable Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flowable Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flowable Hemostats.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flowable Hemostats market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flowable Hemostats industry.
Chapter 3: Detailed analysis of Flowable Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Flowable Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Flowable Hemostats in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Flowable Hemostats Sales Value (2020-2031)
1.2.2 Global Flowable Hemostats Sales Volume (2020-2031)
1.2.3 Global Flowable Hemostats Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Flowable Hemostats Market Dynamics
2.1 Flowable Hemostats Industry Trends
2.2 Flowable Hemostats Industry Drivers
2.3 Flowable Hemostats Industry Opportunities and Challenges
2.4 Flowable Hemostats Industry Restraints
3 Flowable Hemostats Market by Company
3.1 Global Flowable Hemostats Company Revenue Ranking in 2024
3.2 Global Flowable Hemostats Revenue by Company (2020-2025)
3.3 Global Flowable Hemostats Sales Volume by Company (2020-2025)
3.4 Global Flowable Hemostats Average Price by Company (2020-2025)
3.5 Global Flowable Hemostats Company Ranking (2023-2025)
3.6 Global Flowable Hemostats Company Manufacturing Base and Headquarters
3.7 Global Flowable Hemostats Company Product Type and Application
3.8 Global Flowable Hemostats Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Flowable Hemostats Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Flowable Hemostats Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Flowable Hemostats Market by Type
4.1 Flowable Hemostats Type Introduction
4.1.1 Porcine Gelatin
4.1.2 Bovine Gelatin
4.2 Global Flowable Hemostats Sales Volume by Type
4.2.1 Global Flowable Hemostats Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Flowable Hemostats Sales Volume by Type (2020-2031)
4.2.3 Global Flowable Hemostats Sales Volume Share by Type (2020-2031)
4.3 Global Flowable Hemostats Sales Value by Type
4.3.1 Global Flowable Hemostats Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Flowable Hemostats Sales Value by Type (2020-2031)
4.3.3 Global Flowable Hemostats Sales Value Share by Type (2020-2031)
5 Flowable Hemostats Market by Application
5.1 Flowable Hemostats Application Introduction
5.1.1 Orthopedic Surgery
5.1.2 General Surgery
5.1.3 Neuro and Spine Surgery
5.1.4 Cardiac Surgery
5.1.5 Vascular Surgery
5.1.6 Others
5.2 Global Flowable Hemostats Sales Volume by Application
5.2.1 Global Flowable Hemostats Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Flowable Hemostats Sales Volume by Application (2020-2031)
5.2.3 Global Flowable Hemostats Sales Volume Share by Application (2020-2031)
5.3 Global Flowable Hemostats Sales Value by Application
5.3.1 Global Flowable Hemostats Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Flowable Hemostats Sales Value by Application (2020-2031)
5.3.3 Global Flowable Hemostats Sales Value Share by Application (2020-2031)
6 Flowable Hemostats Regional Sales and Value Analysis
6.1 Global Flowable Hemostats Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Flowable Hemostats Sales by Region (2020-2031)
6.2.1 Global Flowable Hemostats Sales by Region: 2020-2025
6.2.2 Global Flowable Hemostats Sales by Region (2026-2031)
6.3 Global Flowable Hemostats Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Flowable Hemostats Sales Value by Region (2020-2031)
6.4.1 Global Flowable Hemostats Sales Value by Region: 2020-2025
6.4.2 Global Flowable Hemostats Sales Value by Region (2026-2031)
6.5 Global Flowable Hemostats Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Flowable Hemostats Sales Value (2020-2031)
6.6.2 North America Flowable Hemostats Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Flowable Hemostats Sales Value (2020-2031)
6.7.2 Europe Flowable Hemostats Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Flowable Hemostats Sales Value (2020-2031)
6.8.2 Asia-Pacific Flowable Hemostats Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Flowable Hemostats Sales Value (2020-2031)
6.9.2 South America Flowable Hemostats Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Flowable Hemostats Sales Value (2020-2031)
6.10.2 Middle East & Africa Flowable Hemostats Sales Value Share by Country, 2024 VS 2031
7 Flowable Hemostats Country-level Sales and Value Analysis
7.1 Global Flowable Hemostats Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Flowable Hemostats Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Flowable Hemostats Sales by Country (2020-2031)
7.3.1 Global Flowable Hemostats Sales by Country (2020-2025)
7.3.2 Global Flowable Hemostats Sales by Country (2026-2031)
7.4 Global Flowable Hemostats Sales Value by Country (2020-2031)
7.4.1 Global Flowable Hemostats Sales Value by Country (2020-2025)
7.4.2 Global Flowable Hemostats Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.5.2 USA Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.6.2 Canada Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.8.2 Germany Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.9.2 France Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.9.3 France Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.11.2 Italy Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.12.2 Spain Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.13.2 Russia Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.16.2 China Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.16.3 China Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.17.2 Japan Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.19.2 India Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.19.3 India Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.20.2 Australia Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.24.2 Chile Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.26.2 Peru Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.28.2 Israel Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.29.2 UAE Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.31.2 Iran Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Flowable Hemostats Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Flowable Hemostats Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Flowable Hemostats Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Teleflex Incorporated
8.1.1 Teleflex Incorporated Comapny Information
8.1.2 Teleflex Incorporated Business Overview
8.1.3 Teleflex Incorporated Flowable Hemostats Sales, Value and Gross Margin (2020-2025)
8.1.4 Teleflex Incorporated Flowable Hemostats Product Portfolio
8.1.5 Teleflex Incorporated Recent Developments
8.2 Baxter International
8.2.1 Baxter International Comapny Information
8.2.2 Baxter International Business Overview
8.2.3 Baxter International Flowable Hemostats Sales, Value and Gross Margin (2020-2025)
8.2.4 Baxter International Flowable Hemostats Product Portfolio
8.2.5 Baxter International Recent Developments
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Comapny Information
8.3.2 Johnson & Johnson Business Overview
8.3.3 Johnson & Johnson Flowable Hemostats Sales, Value and Gross Margin (2020-2025)
8.3.4 Johnson & Johnson Flowable Hemostats Product Portfolio
8.3.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Flowable Hemostats Value Chain Analysis
9.1.1 Flowable Hemostats Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Flowable Hemostats Sales Mode & Process
9.2 Flowable Hemostats Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Flowable Hemostats Distributors
9.2.3 Flowable Hemostats Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.